In recent trading, shares of Aurinia Pharmaceuticals Inc (Symbol: AUPH) have crossed above the average analyst 12-month target price of $11.00, changing hands for $11.45/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downg